Insuman Comb 25 Solostar

Insulin Human, the active ingredient in Insuman Comb 25 Solostar, is a insulin presented as a premixed insulin solution for subcutaneous use. It treats diabetes mellitus in both type 1 and type 2 patients.

GNH USA supplies Insuman Comb 25 Solostar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Comb 25 Solostar is a premixed human insulin used in the management of diabetes mellitus.

- Type 1 diabetes mellitus: provides basal and prandial insulin coverage to control blood glucose. - Type 2 diabetes mellitus: assists in achieving glycemic targets when diet, exercise, and oral agents are insufficient. - Gestational diabetes mellitus (when prescribed): offers rapid‑acting and intermediate‑acting insulin components for tight glucose control.

Insuman Comb 25 Solostar may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects: - Hypoglycemia: symptoms such as sweating, tremor, or confusion due to low blood glucose. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: increase in body weight associated with insulin therapy. - Lipodystrophy: localized changes in fat tissue at injection sites.

Serious or Rare Side Effects: - Allergic reaction: rash, urticaria, or anaphylaxis requiring immediate medical attention. - Severe hypoglycemia with loss of consciousness or seizures. - Insulin edema: rapid fluid retention leading to swelling, particularly in lower extremities.

When using Insuman Comb 25 Solostar, several precautions should be observed.

- Dose adjustment: modify dose based on blood glucose monitoring and clinical response. - Hypoglycemia risk: educate patients on recognizing and treating low blood glucose promptly. - Renal impairment: monitor kidney function and consider dose reduction in severe impairment. - Concomitant medications: assess for drugs that may mask hypoglycemia symptoms. - Pregnancy and lactation: use only if benefits outweigh potential risks and under medical supervision. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 25 Solostar can interact with other medicines, requiring attention to the level of interaction.

Major Interactions (Avoid): - Beta‑blockers: may mask hypoglycemia symptoms and prolong insulin action. - MAO‑A inhibitors: can potentiate insulin’s glucose‑lowering effect, increasing hypoglycemia risk.

Moderate Interactions (Monitor Closely): - Oral hypoglycemic agents (e.g., sulfonylureas, meglitinides): additive glucose‑lowering effect; monitor for hypoglycemia. - Corticosteroids: may raise blood glucose, requiring insulin dose adjustments. - Thiazide diuretics: can impair glucose tolerance, necessitating closer monitoring.